Quality Control and Quality Assurance

At LIHI Pharma, quality is an important consideration in pharmaceutical sourcing, trading, and export activities. We work with carefully selected manufacturing partners whose facilities are expected to meet applicable quality and regulatory requirements, including relevant WHO-GMP standards and Revised Schedule M requirements, where applicable. Our focus is on coordinating with relevant partners to support the supply of pharmaceutical products that meet agreed specifications and applicable market requirements.

Quality assurance involves appropriate quality systems and procedures throughout the relevant stages of pharmaceutical manufacturing and supply. Depending on the product and responsible manufacturing partner, these may include supplier qualification, raw material controls, documented manufacturing procedures, process monitoring, packaging checks, and product release procedures. LIHI Pharma coordinates with relevant partners regarding available product quality information and documentation, as applicable.

Quality control testing and laboratory analysis are performed by the responsible manufacturing partner or other appropriately qualified facilities, according to the product's requirements and applicable regulations. Relevant quality documentation, such as a Certificate of Analysis (COA), may be coordinated where available and applicable. Testing facilities, analytical instruments, validation procedures, and laboratory capabilities depend on the responsible partner and are not represented as LIHI Pharma's own facilities.

LIHI Pharma aims to maintain a quality-focused approach through responsible sourcing, clear communication, and coordination with pharmaceutical partners. We recognize the importance of product quality, safety, consistency, and appropriate documentation in supporting customer confidence and reliable pharmaceutical supply.